Nikolaos Andreatos1, Neda Amini1, Faiz Gani1, Georgios A Margonis1, Kazunari Sasaki1, Vanessa M Thompson2, David J Bentrem3, Bruce L Hall4, Henry A Pitt5, Ana Wilson1, Timothy M Pawlik6,7. 1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. National Surgical Quality Improvement Program, American College of Surgeons, Chicago, IL, USA. 3. Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 4. Department of Surgery, Washington University School of Medicine at St. Louis, St. Louis, MO, USA. 5. Department of Surgery, Temple University Health System, Philadelphia, PA, USA. 6. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. tim.pawlik@osumc.edu. 7. Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research Wexner Medical Center at The Ohio State University, 395 W. 12th Avenue, Suite 670, Columbus, OH, 43210, USA. tim.pawlik@osumc.edu.
Abstract
INTRODUCTION: Post-operative bile leak (BL) and post hepatectomy liver failure (PHLF) are the major potential sources of morbidity among patients undergoing liver resection. We sought to define the incidence of BL and PHLF among a large cohort of patients, as well as examine the prognostic impact of model for end-stage liver disease (MELD) and albumin-bilirubin (ALBI) scores to predict these short-term outcomes. MATERIALS AND METHODS: Patients who underwent a hepatectomy between January 1, 2014 and December 31, 2014 were identified using the National Surgical Quality Improvement Program (NSQIP) liver-targeted database. Risk factors for BL and PHLF were identified using multivariable logistic regression. RESULTS: Among the 3064 patients identified, median age was 60 years (IQR 50-68). Most patients underwent surgery (78.9 %) for malignant lesions. Post-operatively, 250 (8.5 %) patients experienced a BL while PHLF occurred in 149 cases (4.9 %). Both MELD (MELD <10 4.9 %; MELD ≥10, 10 %; P = 0.001) and ALBI (grade 1, 4.0 %; grade 2, 7.2 %; grade 3, 10.0 %; P = 0.001) were associated with PHLF occurrence, while only ALBI predicted PHLF severity (P = 0.008). Moreover, ALBI was associated with BL (grade 1, 7.1 %; grade 2, 11.5 %; grade 3, 14.0 %; P < 0.001), whereas MELD was not (MELD <10, 8.4 %; MELD ≥10, 11.2 %; P = 0.13). On multivariable analysis, ALBI grade 2/3 was associated with PHLF (OR 1.57, 95 % CI 1.08-2.27; P = 0.02), PHLF severity (OR 3.06, 95 % CI 1.50-6.23; P = 0.003), and the development of a BL (OR 1.35, 95 % CI 1.02-1.80; P = 0.04). CONCLUSION: The ALBI score was associated with short-term post-operative outcomes following hepatic resection and represents a useful pre-operative risk-assessment tool to identify patients at risk for adverse post-operative outcomes.
INTRODUCTION: Post-operative bile leak (BL) and post hepatectomy liver failure (PHLF) are the major potential sources of morbidity among patients undergoing liver resection. We sought to define the incidence of BL and PHLF among a large cohort of patients, as well as examine the prognostic impact of model for end-stage liver disease (MELD) and albumin-bilirubin (ALBI) scores to predict these short-term outcomes. MATERIALS AND METHODS:Patients who underwent a hepatectomy between January 1, 2014 and December 31, 2014 were identified using the National Surgical Quality Improvement Program (NSQIP) liver-targeted database. Risk factors for BL and PHLF were identified using multivariable logistic regression. RESULTS: Among the 3064 patients identified, median age was 60 years (IQR 50-68). Most patients underwent surgery (78.9 %) for malignant lesions. Post-operatively, 250 (8.5 %) patients experienced a BL while PHLF occurred in 149 cases (4.9 %). Both MELD (MELD <10 4.9 %; MELD ≥10, 10 %; P = 0.001) and ALBI (grade 1, 4.0 %; grade 2, 7.2 %; grade 3, 10.0 %; P = 0.001) were associated with PHLF occurrence, while only ALBI predicted PHLF severity (P = 0.008). Moreover, ALBI was associated with BL (grade 1, 7.1 %; grade 2, 11.5 %; grade 3, 14.0 %; P < 0.001), whereas MELD was not (MELD <10, 8.4 %; MELD ≥10, 11.2 %; P = 0.13). On multivariable analysis, ALBI grade 2/3 was associated with PHLF (OR 1.57, 95 % CI 1.08-2.27; P = 0.02), PHLF severity (OR 3.06, 95 % CI 1.50-6.23; P = 0.003), and the development of a BL (OR 1.35, 95 % CI 1.02-1.80; P = 0.04). CONCLUSION: The ALBI score was associated with short-term post-operative outcomes following hepatic resection and represents a useful pre-operative risk-assessment tool to identify patients at risk for adverse post-operative outcomes.
Entities:
Keywords:
Albumin; Bile leak; Bilirubin; Liver failure; MELD; Outcomes
Authors: Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz Journal: Surgery Date: 2011-01-14 Impact factor: 3.982
Authors: Misha D P Luyer; Wim A Buurman; M'hamed Hadfoune; Jan A Jacobs; Sergey R Konstantinov; Cornelis H C Dejong; Jan Willem M Greve Journal: Shock Date: 2004-01 Impact factor: 3.454
Authors: Emily C Bellavance; Kimberly M Lumpkins; Gilles Mentha; Hugo P Marques; Lorenzo Capussotti; Carlo Pulitano; Pietro Majno; Paulo Mira; Laura Rubbia-Brandt; Alessandro Ferrero; Luca Aldrighetti; Steven Cunningham; Nadia Russolillo; Benjamin Philosophe; Eduardo Barroso; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2008-08-15 Impact factor: 3.452
Authors: Rebecca A Schroeder; Carlos E Marroquin; Barbara Phillips Bute; Shukri Khuri; William G Henderson; Paul C Kuo Journal: Ann Surg Date: 2006-03 Impact factor: 12.969
Authors: Giuseppe Zimmitti; Robert E Roses; Andreas Andreou; Junichi Shindoh; Steven A Curley; Thomas A Aloia; Jean-Nicolas Vauthey Journal: J Gastrointest Surg Date: 2012-09-07 Impact factor: 3.452
Authors: Bolanle Asiyanbola; David Chang; Ana Luiza Gleisner; Hari Nathan; Michael A Choti; Richard D Schulick; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2008-02-12 Impact factor: 3.452
Authors: Eleni Gkika; Dominik Bettinger; Leo Krafft; Michael Schultheiss; Hannes Philipp Neeff; Lars Maruschke; Michaela Schulenburg; Sonja Adebahr; Simon Kirste; Ursula Nestle; Robert Thimme; Anca-Ligia Grosu; Thomas Baptist Brunner Journal: Strahlenther Onkol Date: 2018-01-10 Impact factor: 3.621
Authors: Nicole Bernardi; Marcio F Chedid; Tomaz J M Grezzana-Filho; Aljamir D Chedid; Marcelo A Pinto; Ian Leipnitz; João E Prediger; Carolina Prediger; Ariane N Backes; Thais O Hammes; Lea T Guerra; Alexandre de Araujo; Mario R Alvares-da-Silva; Cleber R P Kruel Journal: Dig Dis Sci Date: 2019-01-14 Impact factor: 3.199
Authors: Linda M Pak; Jayasree Chakraborty; Mithat Gonen; William C Chapman; Richard K G Do; Bas Groot Koerkamp; Kees Verhoef; Ser Yee Lee; Marco Massani; Eric P van der Stok; Amber L Simpson Journal: J Am Coll Surg Date: 2018-02-15 Impact factor: 6.113
Authors: Giovanni Marasco; Luigina Vanessa Alemanni; Antonio Colecchia; Davide Festi; Franco Bazzoli; Giuseppe Mazzella; Marco Montagnani; Francesco Azzaroli Journal: J Clin Med Date: 2021-05-08 Impact factor: 4.241
Authors: Kamil Pufal; Alexander Lawson; James Hodson; Mansoor Bangash; Jaimin Patel; Chris Weston; Thomas van Gulik; Bobby Vm Dasari Journal: Ann Hepatobiliary Pancreat Surg Date: 2021-05-31